Abstract:Inflammasomes are important sentinels of innate immune defense; they sense pathogens and induce the cell death of infected cells, playing key roles in inflammation, development, and cancer. Several inflammasome sensors detect and respond to specific pathogen- and damage-associated molecular patterns (PAMPs and DAMPs, respectively) by forming a multiprotein complex with the adapters ASC and caspase-1. During disease, cells are exposed to several PAMPs and DAMPs, leading to the concerted activation of multiple inflammasomes. However, the molecular mechanisms that integrate multiple inflammasome sensors to facilitate optimal host defense remain unknown. Here, we discovered that simultaneous inflammasome activation by multiple ligands triggered multiple types of programmed inflammatory cell death, and these effects could not be mimicked by treatment with a pure ligand of any single inflammasome. Furthermore, NLRP3, AIM2, NLRC4, and Pyrin were determined to be members of a large multiprotein complex, along with ASC, caspase-1, caspase-8, and RIPK3, and this complex drove PANoptosis. Furthermore, this multiprotein complex was released into the extracellular space and retained as multiple inflammasomes. Multiple extracellular inflammasome particles could induce inflammation after their engulfment by neighboring macrophages. Collectively, our findings define a previously unknown regulatory connection and molecular interaction between inflammasome sensors, which drives the assembly of a multiprotein complex that includes multiple inflammasome sensors and cell death regulators. The discovery of critical interactions among NLRP3, AIM2, NLRC4, and Pyrin represents a new paradigm in understanding the functions of these molecules in innate immunity and inflammasome biology as well as identifying new therapeutic targets for NLRP3-, AIM2-, NLRC4- and Pyrin-mediated diseases.

AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA

Role of AIM2 inflammasome in inflammatory diseases, cancer and infection

Cutting edge: Cytosolic bacterial DNA activates the inflammasome via Aim2

AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence

Antagonism of the STING Pathway via Activation of the AIM2 Inflammasome by Intracellular DNA

Immunobiology and structural biology of AIM2 inflammasome

The role of AIM2 in inflammation and tumors

New insights into nucleic acid sensor AIM2: The potential benefit in targeted therapy for cancer

Absent in Melanoma 2 Mediates Inflammasome Signaling Activation against Clostridium perfringens Infection

AIM2 in Regulatory T Cells Restrains Autoimmune Diseases.

The AIM2 inflammasome: A novel biomarker and target in cardiovascular disease

Integrated NLRP3, AIM2, NLRC4, Pyrin inflammasome activation and assembly drive PANoptosis

Cytoplasmic DNA and AIM2 inflammasome in RA: where they come from and where they go?

Activation and Pharmacological Regulation of Inflammasomes

The emerging roles of absent in melanoma 2 (AIM2) inflammasome in central nervous system disorders

The Dna-Sensing Aim2 Inflammasome Controls Radiation-Induced Cell Death and Tissue Injury

The complex role of AIM2 in autoimmune diseases and cancers

AIM2 facilitates the apoptotic DNA-induced systemic lupus erythematosus via arbitrating macrophage functional maturation

Crosstalk between inflammasome sensors and DNA damage response pathways

Macrophage IL-1β contributes to tumorigenesis through paracrine AIM2 inflammasome activation in the tumor microenvironment

PANoptosome signaling and therapeutic implications in infection: central role for ZBP1 to activate the inflammasome and PANoptosis